Jade Biosciences, Inc. (JBIO) Balance Sheet
As of 2026-06-30 (10-Q), Jade Biosciences, Inc. (JBIO) reported total assets of $472.1M, total liabilities of $32.2M and shareholders' equity of $439.9M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $107.3M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
JBIOJade Biosciences, Inc.Follow JBIO — free
—
Price chart with a free account
- Market cap
- 927.9M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 11 Nov, in 18 days
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 54.2 | 22.4 | 23.5 | 69.4 | 88.4 | 107.3 | |
| Short-term investments | 113.2 | 106.8 | 98.9 | 0.0 | 247.7 | 354.0 | |
| Current assets | 174.3 | 131.5 | 124.2 | 69.7 | 348.8 | 471.3 | |
| Total assets | 175.4 | 135.3 | 127.4 | 72.8 | 349.8 | 472.1 | |
| Current liabilities | 2.6 | 7.8 | 17.6 | 12.0 | 16.5 | 31.6 | |
| Total liabilities | 2.9 | 8.6 | 18.0 | 119.6 | 17.3 | 32.2 | |
| Shareholders' equity | 172.4 | 126.7 | 109.5 | -46.8 | 332.5 | 439.9 |
USD millions · SEC XBRL
Jade Biosciences, Inc. — questions
- How much cash does Jade Biosciences, Inc. have?
- $107.3M in cash and cash equivalents as of 2026-06-30.
- What are Jade Biosciences, Inc.'s total assets?
- $472.1M as of 2026-06-30.
- What is Jade Biosciences, Inc.'s shareholders' equity?
- $439.9M as of 2026-06-30.
Every figure on this page comes from Jade Biosciences, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.